Creative Biolabs to Host Webinar on Next-Generation Tumoroid-on-a-Chip Technology

Creative Biolabs is set to host an online webinar on August 22, 2025, focusing on the tumoroid-on-a-chip platform, a microfluidic-based 3D tumor model designed to offer more physiologically relevant conditions for preclinical testing. The webinar, presented by Dr. Mohsen Akbari, an Associate Professor from the University of Victoria and Director of the Laboratory for Innovations in Microengineering (LiME), aims to explore the advancements in microfluidic platforms for cancer research.

The tumoroid-on-a-chip technology represents a significant leap forward from traditional 2D cultures by incorporating key structural and cellular features of solid tumors, thereby providing a more accurate assessment of drug responses. This innovation has the potential to significantly impact early-stage drug development and immunotherapy screening by offering a more representative in vitro environment.

Key topics of the webinar include the evolution from multi-compartment tumor chips to high-throughput tumoroid-on-plate systems, strategies for incorporating cellular heterogeneity and ECM complexity, and applications in preclinical drug testing and personalized oncology. This event is open to researchers and professionals in oncology, drug development, and related fields, highlighting the importance of this technology in bridging the gap between laboratory research and clinical practice.

Creative Biolabs, known for its comprehensive portfolio of 3D tumor modeling platforms, continues to support oncology research and therapeutic development by engineering high-fidelity human tumors. These platforms, including Ex Vivo Tissue Models, Precision-Cut Tissue Slicing Models, 3D Spheroid Models, 3D Organoid Models, and Organ-on-a-Chip Models, enable researchers to evaluate drug responses under conditions that closely mimic the in vivo tumor microenvironment.